Cardiovascular risk in obese women with polycystic ovary syndrome: A Framingham Scoring

被引：0
|
作者：
Bozic, I. [1 ]
Macut, D. [1 ]
Popovic, B. [1 ]
Isailovic, T. [1 ]
Petakov, M. [1 ]
Ognjanovic, S. [1 ]
Damjanovic, S. [1 ]
机构：
[1] Univ Belgrade, Inst Endocrinol, Belgrade, Serbia
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)80496-4
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
下载
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [21] Polycystic Ovary Syndrome: A Major Unrecognized Cardiovascular Risk Factor in Women
    Alexander, Carolyn J.
    Tangchitnob, Edward P.
    Lepor, Norman E.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2009, 10 (02) : 83 - 90
  • [22] Cardiovascular disease risk in young Indian women with polycystic ovary syndrome
    Guleria, A. K.
    Syal, S. K.
    Kapoor, A.
    Kumar, S.
    Tiwari, P.
    Dabadghao, P.
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (01) : 26 - 29
  • [23] The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women
    Ilie, Ioana R.
    Pepene, Carmen E.
    Marian, Ioan
    Mocan, Teodora
    Hazi, Georgeta
    Dragotoiu, Gheorghe
    Ilie, Razvan
    Mocan, Lucian
    Duncea, Ileana
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2011, 6 (01): : 64 - 75
  • [24] Cigarette Smoking and Cardiovascular Risk in Young Women with Polycystic Ovary Syndrome
    Morotti, Elena
    Battaglia, Bruno
    Fabbri, Raffaella
    Paradisi, Roberto
    Venturoli, Stefano
    Battaglia, Cesare
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2014, 7 (04) : 301 - 312
  • [25] The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
    Dawson, Alison J.
    Sathyapalan, Thozhukat
    Vince, Rebecca
    Coady, Anne-Marie
    Ajjan, Ramzi A.
    Kilpatrick, Eric S.
    Atkin, Stephen L.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [26] Cardiovascular health in women with polycystic ovary syndrome
    Sukalich, S
    Guzick, D
    SEMINARS IN REPRODUCTIVE MEDICINE, 2003, 21 (03) : 309 - 315
  • [27] Frequency of Non-Obese Women with Polycystic Ovary Syndrome and Efficacy of Metformin in Non-Obese Women with Polycystic Ovary Syndrome
    Qadir, Sara
    Aslam, Tauqeer
    Rabbani, Maryam
    Malik, Sajid
    Rabbani, Amna
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (03): : 898 - 899
  • [28] Effect of orlistat on obese women with polycystic ovary syndrome
    Jiang Qi
    Shi Yuhua
    生物组学研究杂志(英文), 2018, (03) : 128 - 131
  • [29] Dysregulated adipocytokines in obese women with polycystic ovary syndrome
    Shorakae, Soulmaz
    Abell, Sally
    de Courten, Barbora
    Lambert, Gavin
    Hiam, Danielle
    Stepto, Nigel
    Jona, Eveline
    Moran, Lisa
    Teede, Helena
    CLINICAL ENDOCRINOLOGY, 2017, 86 : 9 - 9
  • [30] Subclinical inflammation in obese women with polycystic ovary syndrome
    Elkholi, Dina
    Hammoudah, Sahar
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2012, 17 (03) : 195 - 202
12345